Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.
Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.
In current practice, management of coagulation during liver transplantation is performed
 either through standard coagulation status or with ROTEM® depending on practitioner choice
 and availability of materials. In this context, the ROTEM® is used since over 2 years by
 anesthesiologists in the digestive surgery department of the Croix Rousse hospital in Lyon,
 France.

 Indeed liver transplantation surgery is at high risk of bleeding due to coagulopathy
 developed by patients who are eligible, due to coagulation factor synthesis deficiencies in
 the cirrhotic liver. On the other hand the standard coagulation profile is a poor reflection
 of coagulopathy in such patients because the imbalance between pro- and anti-coagulant
 factors are not taken into account by PT and aPTT measures. Management of intraoperative
 hemorrhage may be facilitated by the ROTEM® which is performed from whole blood and which
 allows the detection of abnormalities in the balance between pro- and anti-coagulant factors.

 This technique was already evaluated in liver, cardiac, and obstetric surgery but also in
 traumatology. Randomized trials in liver transplantation surgery have shown changes in
 transfusion practices but did not focus on the consequences of such changes.
Inclusion Criteria:

 -  Patients >=18 years of age

 -  Patients undergoing orthotopic liver transplantation in the Croix-Rousse Hospital
 within 24 months after inclusion and who have received clear information and who are
 not opposed to the participation in the study

 -  Patients affiliated to a social security system or similar

 -  Patients not subject to a measure of legal protection

 Exclusion Criteria:

 -  Opposition to participation in the study

 -  Patients <18 years of age

 -  Patients who participated in the previous month to another study protocol

 -  Pregnant women or breast-feeding

 -  Not affiliated to a social security system

 -  Patients with hemostasis pathology (hemophilia, ...)